# Antithrombotic Activities of Sotagliflozin vs. Empagliflozin

> **NCT06618976** · PHASE4 · COMPLETED · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 17 (actual)

## Conditions studied

- Thrombosis

## Interventions

- **DRUG:** Sotagliflozin
- **DRUG:** Empagliflozin

## Key facts

- **NCT ID:** NCT06618976
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-02-25
- **Primary completion:** 2026-02-10
- **Final completion:** 2026-02-10
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2026-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06618976

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06618976, "Antithrombotic Activities of Sotagliflozin vs. Empagliflozin". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06618976. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*